2003peer-reviewed2,612 citations
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
John J.V. McMurray, Jan Östergren, Karl Swedberg, Christopher B. Granger, Peter Held, Eric L. Michelson +3 more
The Lancet
Concepts
CandesartanMedicineEjection fractionHeart failureInternal medicineCardiologyHazard ratioPlacebo